Melissa Hollo: Closing the Gap in Maternal Anemia Care Through HerCare
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared a post on LinkedIn:
“Anemia in pregnancy is common, but its impact is often underestimated.
A recent UpToDate review by Michael Auerbach, Helain Landy and Thomas G. DeLoughery, highlights how untreated iron deficiency anemia can increase the risk of preterm birth, postpartum hemorrhage, and adverse outcomes for both mother and baby.
The challenge isn’t lack of testing, the signals often exist early in routine lab data.
The challenge is identifying those risks early enough to act.
That’s why we built HerCare: to analyze lab data, surface maternal risks earlier in pregnancy, and support clinicians with timely, guideline-informed insights.
Because improving maternal outcomes starts long before delivery.
Learn how we’re supporting earlier maternal risk detection.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke